(HNI) HNI - Ratings and Ratios
Office Chairs, Desks, Fireplaces, Cabinets
HNI EPS (Earnings per Share)
HNI Revenue
Description: HNI HNI August 09, 2025
HNI Corp, listed on the NYSE under the ticker symbol HNI, operates in the Office Services & Supplies sub-industry. The companys stock performance is characterized by its current price relative to various moving averages, indicating potential trends and investor sentiment.
From a fundamental perspective, HNI Corp has a market capitalization of approximately $2.08 billion, with a price-to-earnings ratio of 14.73 and a forward P/E of 14.97, suggesting a relatively stable earnings outlook. The return on equity stands at 19.59%, indicating a strong ability to generate profits from shareholder equity.
Key performance indicators (KPIs) to monitor for HNI Corp include revenue growth, operating margin, and return on assets (ROA). The office services and supplies industry is influenced by economic drivers such as GDP growth, office vacancy rates, and corporate spending on furniture and supplies. A growing economy with decreasing office vacancy rates could positively impact HNI Corps revenue.
To evaluate HNI Corps potential, its essential to analyze its financial statements, focusing on metrics such as debt-to-equity ratio, interest coverage, and cash flow generation. These metrics provide insights into the companys financial health, leverage, and ability to invest in growth opportunities or return capital to shareholders.
The office services and supplies market is subject to trends such as the shift towards flexible workspaces and sustainable office products. HNI Corps ability to adapt to these trends and maintain its competitive edge will be crucial to its long-term success. Monitoring the companys product innovation, customer satisfaction, and market share will be essential in assessing its future prospects.
HNI Stock Overview
| Market Cap in USD | 1,897m |
| Sub-Industry | Office Services & Supplies |
| IPO / Inception | 1990-03-26 |
HNI Stock Ratings
| Growth Rating | 21.6% |
| Fundamental | 68.3% |
| Dividend Rating | 58.5% |
| Return 12m vs S&P 500 | -32.5% |
| Analyst Rating | 5.0 of 5 |
HNI Dividends
| Dividend Yield 12m | 3.33% |
| Yield on Cost 5y | 4.75% |
| Annual Growth 5y | 1.80% |
| Payout Consistency | 98.6% |
| Payout Ratio | 38.1% |
HNI Growth Ratios
| Growth Correlation 3m | -4.8% |
| Growth Correlation 12m | -45.8% |
| Growth Correlation 5y | 61.5% |
| CAGR 5y | 15.80% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.54 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.71 |
| Sharpe Ratio 12m | -1.17 |
| Alpha | -35.09 |
| Beta | 0.929 |
| Volatility | 36.91% |
| Current Volume | 481.6k |
| Average Volume 20d | 481.6k |
| Stop Loss | 39 (-3%) |
| Signal | -0.21 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (140.9m TTM) > 0 and > 6% of Revenue (6% = 155.9m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -7.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.15% (prev 4.45%; Δ 0.71pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 114.7m <= Net Income 140.9m (YES >=105%, WARN >=100%) |
| Net Debt (441.7m) to EBITDA (358.1m) ratio: 1.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (47.1m) change vs 12m ago -2.28% (target <= -2.0% for YES) |
| Gross Margin 41.58% (prev 25.83%; Δ 15.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 137.3% (prev 108.8%; Δ 28.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.55 (EBITDA TTM 358.1m / Interest Expense TTM 24.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.05
| (A) 0.07 = (Total Current Assets 542.9m - Total Current Liabilities 409.0m) / Total Assets 1.84b |
| (B) 0.34 = Retained Earnings (Balance) 630.0m / Total Assets 1.84b |
| (C) 0.11 = EBIT TTM 213.0m / Avg Total Assets 1.89b |
| (D) 0.67 = Book Value of Equity 675.4m / Total Liabilities 1.01b |
| Total Rating: 3.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.32
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.40% = 1.20 |
| 3. FCF Margin 2.15% = 0.54 |
| 4. Debt/Equity 0.55 = 2.35 |
| 5. Debt/Ebitda 1.23 = 1.42 |
| 6. ROIC - WACC (= 4.82)% = 6.03 |
| 7. RoE 16.94% = 1.41 |
| 8. Rev. Trend 32.04% = 2.40 |
| 9. EPS Trend 49.38% = 2.47 |
What is the price of HNI shares?
Over the past week, the price has changed by -10.02%, over one month by -13.62%, over three months by -10.63% and over the past year by -19.00%.
Is HNI a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HNI is around 39.70 USD . This means that HNI is currently overvalued and has a potential downside of -1.29%.
Is HNI a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HNI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67 | 66.6% |
| Analysts Target Price | 67 | 66.6% |
| ValueRay Target Price | 44 | 9.4% |
HNI Fundamental Data Overview November 01, 2025
P/E Trailing = 13.8893
P/E Forward = 11.7786
P/S = 0.7317
P/B = 2.6639
P/EG = 1.0931
Beta = 0.929
Revenue TTM = 2.60b USD
EBIT TTM = 213.0m USD
EBITDA TTM = 358.1m USD
Long Term Debt = 444.4m USD (from longTermDebt, last quarter)
Short Term Debt = 37.4m USD (from shortTermDebt, last quarter)
Debt = 462.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 441.7m USD (from netDebt column, last quarter)
Enterprise Value = 2.33b USD (1.90b + Debt 462.4m - CCE 32.0m)
Interest Coverage Ratio = 8.55 (Ebit TTM 213.0m / Interest Expense TTM 24.9m)
FCF Yield = 2.40% (FCF TTM 55.9m / Enterprise Value 2.33b)
FCF Margin = 2.15% (FCF TTM 55.9m / Revenue TTM 2.60b)
Net Margin = 5.42% (Net Income TTM 140.9m / Revenue TTM 2.60b)
Gross Margin = 41.58% ((Revenue TTM 2.60b - Cost of Revenue TTM 1.52b) / Revenue TTM)
Gross Margin QoQ = 44.30% (prev 39.75%)
Tobins Q-Ratio = 1.26 (Enterprise Value 2.33b / Total Assets 1.84b)
Interest Expense / Debt = 1.56% (Interest Expense 7.20m / Debt 462.4m)
Taxrate = 28.22% (16.2m / 57.4m)
NOPAT = 152.9m (EBIT 213.0m * (1 - 28.22%))
Current Ratio = 1.33 (Total Current Assets 542.9m / Total Current Liabilities 409.0m)
Debt / Equity = 0.55 (Debt 462.4m / totalStockholderEquity, last quarter 835.9m)
Debt / EBITDA = 1.23 (Net Debt 441.7m / EBITDA 358.1m)
Debt / FCF = 7.90 (Net Debt 441.7m / FCF TTM 55.9m)
Total Stockholder Equity = 831.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 140.9m / Total Assets 1.84b)
RoE = 16.94% (Net Income TTM 140.9m / Total Stockholder Equity 831.5m)
RoCE = 16.69% (EBIT 213.0m / Capital Employed (Equity 831.5m + L.T.Debt 444.4m))
RoIC = 12.63% (NOPAT 152.9m / Invested Capital 1.21b)
WACC = 7.81% (E(1.90b)/V(2.36b) * Re(9.44%) + D(462.4m)/V(2.36b) * Rd(1.56%) * (1-Tc(0.28)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.63%
[DCF Debug] Terminal Value 77.04% ; FCFE base≈116.9m ; Y1≈144.2m ; Y5≈246.0m
Fair Price DCF = 70.96 (DCF Value 3.25b / Shares Outstanding 45.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 49.38 | EPS CAGR: 22.47% | SUE: -0.11 | # QB: 0
Revenue Correlation: 32.04 | Revenue CAGR: 4.95% | SUE: 0.22 | # QB: 0
Additional Sources for HNI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle